Thursday, 30 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Tech and Science > Landmark Study Finds Semaglutide Effectively Treats Serious Liver Disease : ScienceAlert
Tech and Science

Landmark Study Finds Semaglutide Effectively Treats Serious Liver Disease : ScienceAlert

Last updated: May 2, 2025 3:40 am
Share
Landmark Study Finds Semaglutide Effectively Treats Serious Liver Disease : ScienceAlert
SHARE

Semaglutide Shows Promise in Treating Liver Disease

Semaglutide, a key component of weight loss and diabetes drugs like Ozempic and Wegovy, has shown remarkable potential in treating liver disease, specifically Metabolic Dysfunction-Associated Steatohepatitis (MASH). In a phase 3 clinical trial involving 800 participants over 72 weeks, weekly doses of semaglutide were effective in almost two-thirds of patients with MASH.

Liver treatment chart
The treatment had benefits for reducing inflammation and scarring. (Sanyal et al., NEJM, 2025)

Participants in the trial were divided into two groups, with those receiving semaglutide treatment showing significant improvements in MASH and liver fibrosis compared to the placebo group. The drug not only improves liver health but also addresses underlying metabolic issues contributing to the disease.

Semaglutide, a GLP-1 receptor agonist, mimics the natural GLP-1 hormone to regulate metabolic processes such as appetite reduction and blood sugar control. This mechanism of action proves effective in treating obesity, diabetes, and now liver disease by targeting key drivers of MASH.

The ongoing clinical trial will continue for five years with a larger group of participants to assess the long-term effects of semaglutide on MASH. With limited treatment options available for this condition, the potential of semaglutide offers hope for millions of patients.

The study’s findings, published in the New England Journal of Medicine, highlight the promising role of semaglutide in treating liver disease and its metabolic causes. If approved, this drug could provide a much-needed therapeutic option for patients with MASH and fibrosis, addressing the strong link between liver disease and other health conditions.

Overall, semaglutide’s multifaceted benefits in improving liver health and addressing metabolic dysfunction make it a potential game-changer in the treatment of liver disease, offering new hope for patients worldwide.

See also  Physicists Actually Made The 'World's Smallest Violin' For a Serious Reason : ScienceAlert

TAGGED:diseaseEffectivelyfindsLandmarkLiverScienceAlertSemaglutideStudytreats
Share This Article
Twitter Email Copy Link Print
Previous Article Harvard Hires Conservative Lawyers to Fight Trump Administration Harvard Hires Conservative Lawyers to Fight Trump Administration
Next Article Carney wants to build Canada into an energy superpower Carney wants to build Canada into an energy superpower
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Daytime Emmys 2025 Full Winners List (UPDATING)

The 52nd Daytime Emmys are currently taking place at the Pasadena Civic Auditorium, with Mario…

October 17, 2025

2 former governors resigned in scandal. Now they want to be mayors.

Second Chances for Scandal-Plagued Politicians: A Curious Political Landscape In a political climate where past…

March 20, 2025

The Hidden Consequences Of Erasing Medical Debt

This could lead to hospital price inflation, as hospitals may increase their charges to offset…

August 28, 2024

Anti-Israel Columbia protester Mahmoud Khalil can be deported, judge rules, but it won’t happen immediately

Mahmoud Khalil Faces Deportation Over Anti-Israel Activities at Columbia University An immigration judge in Louisiana…

April 11, 2025

USWNT vs. China prediction, where to watch, live stream: storylines, odds, lineups for international friendly

USWNT to Face China in Friendly Match Ahead of 2027 FIFA Women's World Cup The…

June 2, 2025

You Might Also Like

Chimpanzee Metacognition Allows Humanlike Belief Revision
Tech and Science

Chimpanzee Metacognition Allows Humanlike Belief Revision

October 30, 2025
MCP stacks have a 92% exploit probability: How 10 plugins became enterprise security's biggest blind spot
Tech and Science

MCP stacks have a 92% exploit probability: How 10 plugins became enterprise security's biggest blind spot

October 30, 2025
Sorry, but interstellar visitor 3I/ATLAS really is a comet, not aliens
Tech and Science

Sorry, but interstellar visitor 3I/ATLAS really is a comet, not aliens

October 30, 2025
Sorry, but interstellar visitor 3I/ATLAS really is a comet, not aliens
Tech and Science

Sorry, but interstellar visitor 3I/ATLAS really is a comet, not aliens

October 30, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?